Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0000899243-20-027698

Chief Financial Officer bought 5,263 shares at $19.00 ($99,997)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MCKEE WILLIAM Chief Financial Officer 2020-10-06 Purchase +5,263 $19.00 $99,997 5,263 D
Open-market purchases · 5,263 sh · avg $19.00 · $99,997
Loading xslF345X03/doc4.xml…